Immunohistochemistry is a technique that utilizes the principle of antibodies binding specifically to antigens to identify cell proteins in tissue sections and cells. The technique plays a vital role in cancer research, diagnosis, and treatment through visualization of antigens/proteins in cells of a tissue sample by detecting biomolecules.

Market key trends:

Immunohistochemistry antibodies have emerged as the key growing segment driving the revenue growth of the overall immunohistochemistry market. The antibody segment is projected to expand at a CAGR of 8.5% during the forecast period. Rising demand for protein biomarkers and growing application areas of antibodies have boosted the development and adoption of various types of antibodies for research and diagnosis. Moreover, technological advancements including development of fully automated high-throughput systems have improved the use of antibodies for biomarker detection on tissue slides.

Segment Analysis

The Global Immunohistochemistry Market Size is segmented into product, application, end user and region. Based on product, reagents segment dominates the market owing to rising use of reagents in antibody-based biomarker assays for disease diagnosis and research applications. The reagents segment is further sub-segmented into primary antibodies, secondary antibodies, and enzyme labels. By application, oncology segment dominates the market due to increasing prevalence of cancer worldwide. In terms of end user, hospitals and diagnostic laboratories segment holds the major market share due to increased number of hospitals and diagnostics centers worldwide performing IHC tests for disease diagnosis.

Key Takeaways

The global immunohistochemistry market is expected to witness high growth, exhibiting a CAGR of 6.6% over the forecast period, due to increasing prevalence of chronic diseases such as cancer.
North America leads the global immunohistochemistry market, owing to growing geriatric population, increasing healthcare expenditure and growing demand for precision medicine. Asia Pacific is expected to grow at the highest CAGR during the forecast period due to rising healthcare expenditure and presence of immense opportunities for market growth in emerging countries such as India and China.

Read Our More Blogs : https://www.zupyak.com/p/3923380/t/immunohistochemistry-antibodies-are-fastest-growing-segment-fueling-the-growth-of-immunohistochemistry-market